Formyl peptide receptor-like 2

Formyl peptide receptor-like 2
Identifiers
Symbols	FPRL2 ; FPRH1; FPRH2; FML2_HUMAN; FMLPY; RMLP-R-I
External IDs	Template:OMIM5 Template:MGI HomoloGene: 40605
Gene ontology Molecular function Template:GNF GO Template:GNF GO Template:GNF GO Cellular component Template:GNF GO Template:GNF GO Biological process Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a

Formyl peptide receptor-like 2, also known as FPRL2, is a human gene.

See also

• Formyl peptide receptor

Further reading

• Bao L, Gerard NP, Eddy RL; et al. (1992). "Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19". Genomics. 13 (2): 437–40. PMID 1612600.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Durstin M, Gao JL, Tiffany HL; et al. (1994). "Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes". Biochem. Biophys. Res. Commun. 201 (1): 174–9. doi:10.1006/bbrc.1994.1685. PMID 8198572.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Christophe T, Karlsson A, Dugave C; et al. (2001). "The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2". J. Biol. Chem. 276 (24): 21585–93. doi:10.1074/jbc.M007769200. PMID 11285256.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Yang D, Chen Q, Gertz B; et al. (2002). "Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation". J. Leukoc. Biol. 72 (3): 598–607. PMID 12223529.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Christophe T, Karlsson A, Rabiet MJ; et al. (2002). "Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4". Scand. J. Immunol. 56 (5): 470–6. PMID 12410796.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Ernst S, Lange C, Wilbers A; et al. (2004). "An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family". J. Immunol. 172 (12): 7669–76. PMID 15187149.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Harada M, Habata Y, Hosoya M; et al. (2004). "N-Formylated humanin activates both formyl peptide receptor-like 1 and 2". Biochem. Biophys. Res. Commun. 324 (1): 255–61. doi:10.1016/j.bbrc.2004.09.046. PMID 15465011.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Kang HK, Lee HY, Kim MK; et al. (2005). "The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2". J. Immunol. 175 (2): 685–92. PMID 16002663.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Lee HY, Lee SY, Shin EH; et al. (2007). "F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling". Biochem. Biophys. Res. Commun. 359 (4): 985–90. doi:10.1016/j.bbrc.2007.06.001. PMID 17577578.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)